Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-5-8
pubmed:abstractText
We analyze the expression of E-cadherin in bladder transitional cell carcinoma, areas of carcinoma in situ and lymph node metastases, and determine the value of E-cadherin immunoreactivity for predicting disease progression and survival of patients with bladder transitional cell carcinoma.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0022-5347
pubmed:author
pubmed:issnType
Print
pubmed:volume
165
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1473-9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11342899-Aged, pubmed-meshheading:11342899-Aged, 80 and over, pubmed-meshheading:11342899-Cadherins, pubmed-meshheading:11342899-Carcinoma, Transitional Cell, pubmed-meshheading:11342899-Carcinoma in Situ, pubmed-meshheading:11342899-Cystectomy, pubmed-meshheading:11342899-Disease Progression, pubmed-meshheading:11342899-Female, pubmed-meshheading:11342899-Follow-Up Studies, pubmed-meshheading:11342899-Humans, pubmed-meshheading:11342899-Immunohistochemistry, pubmed-meshheading:11342899-Lymph Nodes, pubmed-meshheading:11342899-Lymphatic Metastasis, pubmed-meshheading:11342899-Male, pubmed-meshheading:11342899-Middle Aged, pubmed-meshheading:11342899-Neoplasm Invasiveness, pubmed-meshheading:11342899-Prognosis, pubmed-meshheading:11342899-Survival Rate, pubmed-meshheading:11342899-Tumor Markers, Biological, pubmed-meshheading:11342899-Urinary Bladder Neoplasms
pubmed:year
2001
pubmed:articleTitle
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
pubmed:affiliation
Scott Department of Urology, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't